Tartu University Hospital Clinic of Hematology and Oncology
Tartu, Estonia
About Tartu University Hospital Clinic of Hematology and Oncology
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Mast Therapeutics, Inc.
1
NSABP Foundation Inc
1
Clinical Trials at Tartu University Hospital Clinic of Hematology and Oncology
During the past decade, Tartu University Hospital Clinic of Hematology and Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 9 clinical trials were completed, i.e. on
average, 450% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Tartu University Hospital Clinic of Hematology and Oncology"
#1 collaborator was "AbbVie" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Tartu University Hospital Clinic of Hematology and Oncology
According to Clinical.Site data, the most researched conditions in "Tartu University Hospital Clinic of Hematology and Oncology" are
"Breast Cancer" (3 trials), "Advanced Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Tartu University Hospital Clinic of Hematology and Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Tartu University Hospital Clinic of Hematology and Oncology
Most popular intervention types in "Tartu University Hospital Clinic of Hematology and Oncology" are "Drug" (13 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials), "Placebo" (3 trials), "Trastuzumab" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Tartu University Hospital Clinic of Hematology and Oncology
The vast majority of trials in "Tartu University Hospital Clinic of Hematology and Oncology" are
10 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Tartu University Hospital Clinic of Hematology and Oncology
Currently, there are NaN active trials in "Tartu University Hospital Clinic of Hematology and Oncology".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Tartu University Hospital Clinic of Hematology and Oncology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Tartu University Hospital Clinic of Hematology and Oncology, 1 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".